Dr Milan Anjanappa is a Consultant Clinical Oncologist specialising in the non-surgical treatment of prostate and complex urological cancers. With more than a decade of experience in oncology, he is committed to providing personalised, evidence-based cancer care and helping patients make confident, informed decisions about their treatment. Dr Anjanappa has a busy NHS practice at Mount Vernon Cancer Centre in London, where he has been a Consultant Clinical Oncologist since 2021. He manages a wide range of prostate cancers, including complex and recurrent cases, using advanced radiotherapy and systemic cancer treatments.

Specialist Prostate Cancer Treatment

Dr Anjanappa provides expert care for prostate cancer at every stage, from newly diagnosed and localised disease through to advanced or recurrent cancer.
His specialist expertise includes:

· Precision radiotherapy, including image-guided, stereotactic and MR-guided techniques

· Prostate brachytherapy, including high-dose-rate and low-dose-rate seed treatments
· Hormone therapy and chemotherapy

· Immunotherapy and targeted cancer treatments

· Lu-PSMA radioligand therapy for selected patients with advanced prostate cancer

Treatment can be used alone or in combination, depending on the individual diagnosis, clinical circumstances and personal priorities. Dr Anjanappa has particular experience supporting men who are considering alternatives to surgery, have complex or recurrent disease, require advanced radiotherapy, or are seeking a specialist second opinion. His approach combines technical expertise with a strong focus on preserving quality of life and minimising treatment-related side effects wherever possible.

A Personalised, Patient-Centred Approach

Dr Anjanappa believes that treatment decisions should be made in partnership with patients. He offers longer consultations to give patients sufficient time to understand their diagnosis, discuss available treatment options and consider the potential benefits and risks of each approach. Patients can expect clear explanations, honest discussions and time to ask questions. Rather than automatically recommending a single treatment, Dr Anjanappa explores appropriate options with each patient before developing an individualised treatment plan that reflects their medical needs, lifestyle, family circumstances and personal preferences. He also provides continuity of care and ongoing support throughout treatment and recovery.

Research and Innovation

Dr Anjanappa is actively involved in clinical research focused on improving outcomes for people with prostate cancer. He has participated in clinical trials as both Principal Investigator and Sub-Investigator, including major studies such as STAR-TRAP, POINTER-PC and STAMPEDE 2. He has published research in peer-reviewed medical journals and presented his work at national and international conferences. His involvement in research helps him remain at the forefront of developments in prostate cancer treatment and emerging therapies.

Qualifications and Experience

Dr Anjanappa completed his medical training in India before moving to the UK, where he further developed his expertise in clinical oncology, including experience as a clinical fellow at The Christie Hospital in Manchester. His qualifications include MBBS, MD (Radiotherapy), DNB (Radiotherapy) and FRCR (Fellow of the Royal College of Radiologists). He is registered with the General Medical Council and joined the UK Specialist Register in Clinical Oncology in 2023. He is a member of the Royal College of Radiologists and the European Society for Medical Oncology. Dr Anjanappa combines specialist knowledge, advanced treatment techniques and compassionate care to support men throughout their prostate cancer journey.Qualifications and Experience

Dr Anjanappa completed his medical training in India before moving to the UK, where he further developed his expertise in clinical oncology, including experience as a clinical fellow at The Christie Hospital in Manchester. His qualifications include MBBS, MD (Radiotherapy), DNB (Radiotherapy) and FRCR (Fellow of the Royal College of Radiologists). He is registered with the General Medical Council and joined the UK Specialist Register in Clinical Oncology in 2023. He is a member of the Royal College of Radiologists and the European Society for Medical Oncology. Dr Anjanappa combines specialist knowledge, advanced treatment techniques and compassionate care to support men throughout their prostate cancer journey.

Clinical Interests 

• Prostate Cancer; 5-day prostate radiotherapy (SABR/SBRT)
• Lutetium-PSMA therapy
• MR LINAC SABR
• Prostate brachytherapy
• Seed brachytherapy

Member of European Society of Medical Oncology